HLA-mismatched renal transplantation without maintenance immunosuppression.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 18216355.
- Also identified by DOI 10.1056/NEJMoa071074 and PMC identifier 2819046.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Five patients with end-stage renal disease received combined bone marrow and kidney transplants from HLA single-haplotype mismatched living related donors, with the use of a nonmyeloablative preparative regimen. Transient chimerism and reversible capillary leak syndrome developed in all recipients. Irreversible humoral rejection occurred in one patient. In the other four recipients, it was possible to discontinue all immunosuppressive therapy 9 to 14 months after the transplantation, and renal function has remained stable for 2.0 to 5.3 years since transplantation. The T cells from these four recipients, tested in vitro, showed donor-specific unresponsiveness and in specimens from allograft biopsies, obtained after withdrawal of immunosuppressive therapy, there were high levels of P3 (FOXP3) messenger RNA (mRNA) but not granzyme B mRNA.
Medical subject headings
- Bone Marrow Transplantation
- Kidney Failure, Chronic
- Kidney Transplantation
- Transplantation Chimera
- Transplantation Tolerance